Last Friday, I had an Oncology checkup. This is part of routine post-cancer care for breast cancer. I believe I mentioned here previously my Oncologist called to briefly discuss the possibility of putting me on Tamoxifen instead. Well, this visit was sort of a follow-up on that call.
Like usual, I first saw an intern who was working with my doc. She and I went over the past few months regarding my experiences with the medication regimen I’d been originally placed on, and I mentioned to her my hands had begun intermittently itching. She checked my heart and listened to my lungs, ensured I didn’t have edema in the legs, and went to give her report to my Oncologist. I remember her first name was Amy (’cause it’s very familiar to me), but not her last name.
When she returned, she had my Oncologist, Dr. Colonna with her. My lungs and heart were checked again, then Dr. Colonna sat and we got into the main topic of my visit: what medications would be best for my post-cancer care.
We once again went over the benefits and side effects of Tamoxifen and my Anastrazole-Leuprolide regimen. My main concern with the Tamoxifen is the possible stroke side effect. I know thousands of women have been on Tamoxifen for years without such a side effect, but it’s a main worry for me. I’m concerned about the osteoporosis which the Anastrazole-Leuprolide regimen can cause, but not as much as I am about the stroke issue.
Dr. Colonna wasn’t strongly determined I should switch to the Tamoxifen, and she listened to my concerns about the side effects issues, then suggested I remain on my current regimen for about five years and possibly stop all hormone suppressants. I disliked that idea, mainly because I know that at 45, my body will still be producing hormones; my mother’s menopause didn’t end until she was in her fifties, and I told Dr. Colonna I was expecting my natural menopause to last that long—so I thought I should be on some sort of hormone suppressant therapy until at least my fifties.
She agreed with this, and we eventually worked out I’d remain on the Anastrazole-Leuprolide therapy for five years, then I’d switch to Tamoxifen. I’m to go in annually for DEXA scans of my bones to ensure I’m not losing too much density in them. I suspect if I do, I’ll be switched to the Tamoxifen sooner, but Dr. Colonna said my initial scan showed I had excellent bone density, so she felt confident I could remain on my current regimen for at least five years.
I told her about the itching in my hands, how it’s intermittent, and she explained it may have something to do with the early menopause my body is going through. So, it’s hormones and nothing can be done about it. LOL It’s not that bothersome, so I was just glad to have an answer for why it started up.
I also told Dr. Colonna I’m trans. I probably should have long ago, but I didn’t want Mom present to try to downplay it. It is important for all my caregivers to know, even if I’m not going to be able to do much—if anything—toward transitioning anytime soon.
While I was up at the VA (actually, during the waiting period for my medication refills, including the Leuprolide injection which needs to be administered by a nurse), I made an appointment with my primary care doc to have a regular checkup. My last one was a female exam, and I need to tell Dr. Milne (pron. mil-nee) I’m trans and what my projected plans are. Now that I’m finished with the intensive cancer care, I can better focus on my trans issues, and I’m looking forward to doing so.